Molecular characterization of hemoglobin D Punjab traits and clinical-hematological profile of the patients
Keywords:
Hemoglobinopathies, Hemoglobins, Chromatography, high pressure liquid, Thalassemia, Polymerase chain reactionAbstract
CONTEXT AND OBJECTIVE: Hemoglobin (Hb) D hemoglobinopathies are widespread diseases in northwestern India and usually present with mild hemolytic anemia and mild to moderate splenomegaly. The heterozygous form of Hb D is clinically silent, but coinheritance of Hb D with Hb S or beta-thalassemia produces clinically significant conditions like thalassemia intermedia of moderate severity. Under heterozygous conditions with coinheritance of alpha and beta-thalassemia, patients show a degree of clinical variability. Thus, our aim was to molecularly characterize the Hb D trait among individuals who were clinically symptomatic because of co-inheritance of alpha deletions or any beta-globin gene mutations. DESIGN AND SETTING: This was a cross-sectional study conducted in an autonomous tertiary-care hospital. METHODS: Complete blood count and red cell indices were measured using an automated cell analyzer. Quantitative assessment of hemoglobin Hb F, Hb A, Hb A2 and Hb D was performed by means of high performance liquid chromatography (HPLC). DNA extraction was done using the phenol-chloroform method. Molecular analyses on common alpha deletions and common beta mutations were done using the Gap polymerase chain reaction and Amplification Refractory Mutation System, respectively. RESULTS: We evaluated 30 patients and found clinical variation in the behavior of Hb D traits. In six patients, the Hb D traits were clinically symptomatic and behaved like those of thalassemia intermedia. Molecular characterization showed that three out of these six were IVS-1-5 positive. CONCLUSIONS: HPLC may not be the gold standard for diagnosing symptomatic Hb D Punjab traits. Hence, standard confirmation should include molecular studies.
Downloads
References
Lukens JN. The Abnormal Hemoglobins: General Principles. In. Lee GR, Foerster J, Lukens J, Paraskevas F, Greer JP, Rodgers GM, editors. Wintrobe’s Clinical Hematology. 10th ed. Baltimore: Lippincott Williams & Wilkins; 1998. p. 1329-45.
Ozsoylu S. Homozygous hemoglobin D Punjab. Acta Haematol. 1970;43(6):353-9.
Li HJ, Zhao XN, Qin F, et al. Abnormal hemoglobins in the Silk Road region of China. Hum Genet. 1990;86(2):231-5.
Fioretti G, De Angioletti M, Pagano L, et al. DNA polymorphisms associated with Hb D-Los Angeles [beta 121(GH4)Glu-->Gln] in southern Italy. Hemoglobin. 1993;17(1):9-17.
Husquinet H, Parent MT, Schoos-Barbette S, et al. Hemoglobin D-Los Angeles [beta 121(GH4)Glu Gln] in the Province of Liège, Belgium.
Hemoglobin. 1986;10(6):587-92.
Lischka A, Pollak A, Bauer K, Aschauer H, Braunitzer G. Hemoglobin D “Los Angeles” in an Austrian family: biochemical identification, clinical aspects, and kindred study. Hemoglobin. 1984;8(4):353-61.
Atalay EO, Koyuncu H, Turgut B, et al. High incidence of Hb D-Los Angeles [beta 121(GH4)Glu-->Gln] in Denizli Province, Aegean region of Turkey. Hemoglobin. 2005;29(4):307-10.
Fucharoen S, Changtrakun Y, Surapot S, Fucharoen G, Sanchaisuriya K. Molecular characterization of Hb D-Punjab [beta121(GH4)Glu-->Gln] in Thailand. Hemoglobin. 2002;26(3):261-9.
Yildiz S, Atalay A, Bagci H, Atalay EO. Beta-Thalassemia mutations in Denizli province of Turkey. Turk J Haematol. 2005;22(1):19-23.
Canatan D, Akar N, Arcasoy A. Hb D-Los Angeles/IVS-I-110 (GA) combination in a Turkish woman. Turk J Med Sci. 1992;16(8):585-6.
Bircan I, Sisli S, Güven A, et al. Hemoglobinopathies in the district of Antalya, Turkey. Pediatr Hematol Oncol. 1993;10(3):289-91.
Irken G, Oren H, Undar B, et al. Analysis of thalassemia syndromes and abnormal hemoglobins in patients from the Aegean region of Turkey. Turk J Pediatr. 2002;44(1):21-4.
Altay C. Abnormal hemoglobins in Turkey. Turk J Haematol. 2002;19(1):63-74.
Zeng YT, Huang SZ, Ren ZR, Li HJ. Identification of Hb D-Punjab gene: application of DNA amplification in the study of abnormal hemoglobins. Am J Hum Genet. 1989;44(6):886-9.
Firkin F, Chesterman C, Penington D, Rush B. Disorders of Hemoglobin Structure and Synthesis. de Gruchi’s Clinical Haematology in Medical Practice. 5th ed. Oxford: Blackwell Science; 1996. p. 137-71.
Baysal E, Huisman TH. Detection of common deletional alpha-thalassemia-2 determinants by PCR. Am J Hematol. 1994;46(3):208-13.
Shaji RV, Eunice SE, Baidya S, Srivastava A, Chandy M. Determination of the breakpoint and molecular diagnosis of a common alpha- thalassemia-1 deletion in the Indian population. Br J Haematol. 2003;123(5):942-7.
Chang JG, Lee LS, Lin CP, Chen PH, Chen CP. Rapid diagnosis of alpha-thalassemia-1 of southeast Asia type and hydrops fetalis by polymerase chain reaction. Blood. 1991;78(3):853-4.
Varawalla NY, Old JM, Sarkar R, Venkatesan R, Weatherall DJ. The spectrum of beta-thalassemia mutations on the Indian subcontinent: the basis for prenatal diagnosis. Br J Haematol. 1991;78(2):242-7.
Jain RC. Hemoglobin D disease: report of a case. Am J Clin Pathol. 1971;56(1):40-2.
Ahmed M, Stuhrmann M, Bashawri L, Kühnau W, El-Harith EH. The beta-globin genotype E121Q/W15X (cd121GAA-->CAA/cd15TGG--
>TGA) underlines Hb d/beta-(0) thalassaemia marked by domination of haemoglobin D. Ann Hematol. 2001; 80(11):629-33.
Dash S, Kumar S, Dash RJ. Hematological malignancy in hemoglobin D disease. Am J Hematol. 1988;27(4):305.
Perea FJ, Casas-Castañeda M, Villalobos-Arámbula AR, et al. Hb D-Los Angeles associated with Hb S or beta-thalassemia in four Mexican Mestizo families. Hemoglobin. 1999;23(3):231-7.
el-Kalla S, Mathews AR. Hb D-Punjab in the United Arab Emirates. Hemoglobin. 1997;21(4):369-75.
Tyagi S, Marwaha N, Parmar V, Basu S. Sickle cell hemoglobin-D Punjab disease (Compound Heterozygous state). Ind J Hematol Blood Transf. 2000;18:31-2.
Panigrahi I, Agarwal S, Signhal P. HbD-Punjab associated with HbS:A report of two cases from India. Ind J Hematol Blood Transf. 2000;18:86-7.
Owaidah TM, Al-Saleh MM, Al-Hellani AM. Hemoglobin D/beta- thalassemia and beta-thalassemia major in a Saudi family. Saudi Med J. 2005;26(4):674-7.
Ropero P, González FA, Sánchez J, et al. [The association of beta zero- thalassemia and Hb D Punjab in a family of Indian origin. The second case reported in Spain]. Med Clin (Barc). 1997;108(10):385-8.
Agrawal MG, Bhanushali AA, Dedhia P, et al. Compound heterozygosity of Hb D(Iran) (beta(22) Glu-->Gln) and beta(0)-thalassemia (619 bp- deletion) in India. Eur J Haematol. 2007;79(3):248-50.
Mukherjee MB, Nadkarni AH, Gorakshakar AC, et al. Clinical, hematologic and molecular variability of sickle cell- thalassemia in western India. Indian J Hum Genet. 2010;16(3):154-8.
